Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.

Schildcrout JS, Denny JC, Bowton E, Gregg W, Pulley JM, Basford MA, Cowan JD, Xu H, Ramirez AH, Crawford DC, Ritchie MD, Peterson JF, Masys DR, Wilke RA, Roden DM
Clin Pharmacol Ther. 2012 92 (2): 235-42

PMID: 22739144 · PMCID: PMC3785311 · DOI:10.1038/clpt.2012.66

MeSH Terms (11)

Adult Aged Drug-Related Side Effects and Adverse Reactions Female Genotype Humans Male Middle Aged Patient Safety Pharmacogenetics Polymorphism, Genetic

Connections (5)

This publication is referenced by other Labnodes entities:

Links